Cargando…

Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants

The ongoing pandemic of COVID-19, caused by SARS-CoV-2, has severely impacted the global public health and socio-economic stability, calling for effective vaccines and therapeutics. In this study, we continued our efforts to develop more efficient SARS-CoV-2 fusion inhibitors and achieved significan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Danwei, Zhu, Yuanmei, Jiao, Tao, Wu, Tong, Xiao, Xia, Qin, Bo, Chong, Huihui, Lei, Xiaobo, Ren, Lili, Cui, Sheng, Wang, Jianwei, He, Yuxian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216258/ https://www.ncbi.nlm.nih.gov/pubmed/34057039 http://dx.doi.org/10.1080/22221751.2021.1937329

Ejemplares similares

SARS-CoV-2 fusion-inhibitory lipopeptides maintain high potency against divergent variants of concern including Omicron
por: Zhu, Yuanmei, et al.
Publicado: (2022)

Potent inhibition of diverse Omicron sublineages by SARS-CoV-2 fusion-inhibitory lipopeptides
por: Zhu, Yuanmei, et al.
Publicado: (2022)

SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses
por: Zhu, Yuanmei, et al.
Publicado: (2021)

Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus
por: Yu, Danwei, et al.
Publicado: (2021)

Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity
por: Zhu, Yuanmei, et al.
Publicado: (2020)

Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors
por: Geng, Xiuzhu, et al.
Publicado: (2019)

Monotherapy with a low-dose lipopeptide HIV fusion inhibitor maintains long-term viral suppression in rhesus macaques
por: Chong, Huihui, et al.
Publicado: (2019)

In Vitro Selection and Characterization of HIV-1 Variants with Increased Resistance to LP-40, Enfuvirtide-Based Lipopeptide Inhibitor
por: Hu, Yue, et al.
Publicado: (2022)

Structural and Functional Characterization of the Secondary Mutation N126K Selected by Various HIV-1 Fusion Inhibitors
por: Yu, Danwei, et al.
Publicado: (2020)

Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals
por: Zhu, Yuanmei, et al.
Publicado: (2020)

Preparation and evaluation of amphipathic lipopeptide‐loaded PLGA microspheres as sustained‐release system for AIDS prevention
por: Jin, Huijuan, et al.
Publicado: (2020)

Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern
por: Schmitz, Katharina S., et al.
Publicado: (2022)

Fusion Inhibitory Lipopeptides Engineered for Prophylaxis of Nipah Virus in Primates
por: Mathieu, Cyrille, et al.
Publicado: (2018)

Protocol for evaluating CD8(+) T cell-mediated immunity in latently SHIV-infected rhesus macaques with HIV fusion-inhibitory lipopeptide monotherapy
por: Sun, Yuting, et al.
Publicado: (2022)

Broad-spectrum anti-HIV activity and high drug resistance barrier of lipopeptide HIV fusion inhibitor LP-19
por: He, Lin, et al.
Publicado: (2023)

Development of highly effective LCB1-based lipopeptides targeting the spike receptor-binding motif of SARS-CoV-2
por: Zhu, Yuanmei, et al.
Publicado: (2023)

Resistance profile and mechanism of severe acute respiratory syndrome coronavirus-2 variants to LCB1 inhibitor targeting the spike receptor-binding motif
por: Wu, Tong, et al.
Publicado: (2022)

Design of a Bispecific HIV Entry Inhibitor Targeting the Cell Receptor CD4 and Viral Fusion Protein Gp41
por: Yan, Hongxia, et al.
Publicado: (2022)

Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets
por: de Vries, Rory D., et al.
Publicado: (2020)

Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets
por: de Vries, Rory D., et al.
Publicado: (2021)

Strong inhibitory activities and action modes of lipopeptides on lipase
por: Chen, Mei-chun, et al.
Publicado: (2020)

Cell membrane-anchored anti-HIV single-chain antibodies and bifunctional inhibitors targeting the gp41 fusion protein: new strategies for HIV gene therapy
por: Chen, Yue, et al.
Publicado: (2021)

Structural Insights into the Mechanisms of Action of Short-Peptide HIV-1 Fusion Inhibitors Targeting the Gp41 Pocket
por: Zhang, Xiujuan, et al.
Publicado: (2018)

Identification of a novel HIV-1-neutralizing antibody from a CRF07_BC-infected Chinese donor
por: Sun, Youxiang, et al.
Publicado: (2017)

Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection
por: Lan, Qiaoshuai, et al.
Publicado: (2021)

Biophysical Property and Broad Anti-HIV Activity of Albuvirtide, a 3-Maleimimidopropionic Acid-Modified Peptide Fusion Inhibitor
por: Chong, Huihui, et al.
Publicado: (2012)

Double-Headed Cationic Lipopeptides: An Emerging Class of Antimicrobials
por: Małuch, Izabela, et al.
Publicado: (2020)

Inhibitory Effects of Lipopeptides and Glycolipids on C. albicans–Staphylococcus spp. Dual-Species Biofilms
por: Ceresa, Chiara, et al.
Publicado: (2021)

Generation of HIV-resistant cells with a single-domain antibody: implications for HIV-1 gene therapy
por: Jin, Hongliang, et al.
Publicado: (2021)

Drug Delivery via Cell Membrane Fusion Using Lipopeptide Modified Liposomes
por: Yang, Jian, et al.
Publicado: (2016)

Lipopeptides for Vaccine Development
por: Hamley, Ian W.
Publicado: (2021)

Long-Acting HIV-1 Fusion Inhibitory Peptides and their Mechanisms of Action
por: Wang, Chen, et al.
Publicado: (2019)

Cyclic Lipopeptide Biosynthetic Genes and Products, and Inhibitory Activity of Plant-Associated Bacillus against Phytopathogenic Bacteria
por: Mora, Isabel, et al.
Publicado: (2015)

A Purified Recombinant Lipopeptide as Adjuvant for Cancer Immunotherapy
por: Song, Ying-Chyi, et al.
Publicado: (2014)

Epitope Mapping of M36, a Human Antibody Domain with Potent and Broad HIV-1 Inhibitory Activity
por: Wan, Chao, et al.
Publicado: (2013)

Two M-T hook residues greatly improve the antiviral activity and resistance profile of the HIV-1 fusion inhibitor SC29EK
por: Chong, Huihui, et al.
Publicado: (2014)

Identification of lipopeptides in Bacillus megaterium by two-step ultrafiltration and LC–ESI–MS/MS
por: Ma, Yunxiao, et al.
Publicado: (2016)

Pushing the envelope: Immune mechanism and application landscape of macrophage-activating lipopeptide-2
por: Liao, Daoyong, et al.
Publicado: (2023)

Design and characterization of novel SARS-CoV-2 fusion inhibitors with N-terminally extended HR2 peptides
por: Hu, Yue, et al.
Publicado: (2023)

Inhibitory Effects of Linear Lipopeptides From a Marine Bacillus subtilis on the Wheat Blast Fungus Magnaporthe oryzae Triticum
por: Chakraborty, Moutoshi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k4ma7g5pc1mcr431qmjvhdpnud